Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-05-088811
Filing Date
2005-04-28
Accepted
2005-04-28 17:21:23
Documents
7
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A d10ka.htm 10-K/A 661241
2 CODE OF ETHICS OF THE REGISTRANT dex141.htm EX-14.1 16741
3 CONSENT OF SWENSON ADVISORS, LLP dex231.htm EX-23.1 1711
4 CERTIFICATION dex311.htm EX-31.1 9176
5 CERTIFICATION dex312.htm EX-31.2 9152
6 CERTIFICATION dex321.htm EX-32.1 4632
7 GRAPHIC g49772g08z48.jpg GRAPHIC 69096
  Complete submission text file 0001193125-05-088811.txt   799550
Mailing Address 4370 LA JOLLA VILLAGE DRIVE SUITE 685 SAN DIEGO CA 92122
Business Address 4370 LA JOLLA VILLAGE DRIVE SUITE 685 SAN DIEGO CA 92122 8586460789
AKESIS PHARMACEUTICALS, INC. (Filer) CIK: 0001042420 (see all company filings)

EIN.: 841409219 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-27409 | Film No.: 05781732
SIC: 7389 Services-Business Services, NEC